Merit medical to present 6-month outcomes from randomized arm of wrapsody™ arteriovenous access efficacy (wave) pivotal study at two upcoming medical meetings

South jordan, utah, aug. 01, 2024 (globe newswire) -- merit medical systems, inc. (nasdaq: mmsi), a global leader of healthcare technology, today announced plans to release findings from its wave study. a pivotal, international, multicenter trial, the wave study examines the safety and efficacy of merit's wrapsody cell-impermeable endoprosthesis for treatment of stenosis in the venous outflow circuit.
WAVE Ratings Summary
WAVE Quant Ranking